Literature DB >> 637853

Transformation of arachidonate into 6-oxoprostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 by sheep lung microsomal fraction.

H H Tai, B Yuan, A T Wu.   

Abstract

In the presence of haemoglobin and isoproterenol, the microsomal fraction of sheep lung catalysed the conversion of arachidonate predominantly into thromboxane B2 and to a lesser extent into 6-oxoprostaglandin F1alpha. Very little prostaglandin E2 and prostaglandin F2alpha were formed. If reduced glutathione was added in combination with haemoglobin and isoproterenol, the synthesis of prostaglandin E2 was favoured over that of thromboxane B2 and 6-oxoprostaglandin F1alpha. The identities of these products were confirmed by t.l.c. and by combined g.l.c.-mass spectrometry. These results indicate that microsomal fraction of sheep lung possesses active prostaglandin synthase, prostacyclin synthase and thromboxane synthase activities.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637853      PMCID: PMC1183912          DOI: 10.1042/bj1700441

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma.

Authors:  W C Chang; S Murota; M Matsuo; S Tsurufuji
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

2.  Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung.

Authors:  W Dawson; J R Boot; A F Cockerill; D N Mallen; D J Osborne
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

3.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

4.  The isolation and determination of prostaglandins in lungs of sheep, guinea pig, monkey and man.

Authors:  E Anggård
Journal:  Biochem Pharmacol       Date:  1965-11       Impact factor: 5.858

5.  Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme.

Authors:  N Ogino; T Miyamoto; S Yamamoto; O Hayaishi
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

6.  The chemical structure of prostaglandin X (prostacyclin).

Authors:  N Whittaker; S Bunting; J Salmon; S Moncada; J R Vane; R A Johnson; D R Morton; J H Kinner; R R Gorman; J C McGuire; F F Sun
Journal:  Prostaglandins       Date:  1976-12

7.  Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme.

Authors:  M Hemler; W E Lands
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

8.  Mechanism of prostaglandin biosynthesis in rabbit kidney medulla. A rate-limiting step and the differential stimulatory actions of L-adrenaline and glutathione.

Authors:  H H Tai
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

9.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

10.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  3 in total

Review 1.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

2.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

Review 3.  Pulmonary biosynthesis and metabolism of prostaglandins and related substances.

Authors:  T E Eling; A I Ally
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.